Your session is about to expire
← Back to Search
Contact Lenses
1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for Astigmatism
N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing different types of soft contact lenses. It involves people who already wear these lenses. Participants will try out various lenses and report on their comfort and vision clarity.
Eligible Conditions
- Astigmatism
- Near-sightedness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Visual Acuity
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: kalifilcon A Daily Disposable ToricExperimental Treatment1 Intervention
kalifilcon A Daily Disposable Toric
Group II: Ultra for Astigmatism Contact LensesActive Control1 Intervention
Ultra for Astigmatism Contact Lenses
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
kalifilcon A Daily Disposable Toric
2022
N/A
~30
Find a Location
Who is running the clinical trial?
Bausch & Lomb IncorporatedLead Sponsor
257 Previous Clinical Trials
58,202 Total Patients Enrolled
19 Trials studying Astigmatism
2,429 Patients Enrolled for Astigmatism
Robert SteffenStudy DirectorBausch & Lomb Incorporated
2 Previous Clinical Trials
835 Total Patients Enrolled